These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11828745)

  • 1. [Effect of admixture of commercially available corticosteroid ointments and/or creams on vasoconstrictor activity].
    Ohtani M; Yamada N; Takayama K; Kotaki H; Etoh T; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Jan; 122(1):107-12. PubMed ID: 11828745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the permeability of corticosteroid in hairless mouse and hairless micropig skin from admixture of commercially available corticosteroid ointments and/or creams].
    Ohtani M; Kotaki H; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Aug; 122(8):589-94. PubMed ID: 12187775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Mixing Time and Storage Condition on Characterization of Heparinoid Admixtures with Corticosteroids].
    Sugiyama I; Takahashi N; Sadzuka Y
    Yakugaku Zasshi; 2016; 136(10):1391-1400. PubMed ID: 27725389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of mixing commercially available corticosteroid ointments with other ointments and the anti-inflammatory activity of the admixtures.
    Kizu J; Ichihara W; Tomonaga E; Abe J; Watanabe T; Inoue T; Hori S
    Yakugaku Zasshi; 2004 Feb; 124(2):93-7. PubMed ID: 14978951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of admixture of betamethasone butyrate propionate ointment on preservative efficacy].
    Ohtani M; Nakai T; Ohsawa K; Kim S; Matsumoto M; Etoh T; Kariya S; Kanou S; Uchino K
    Yakugaku Zasshi; 2002 Dec; 122(12):1153-8. PubMed ID: 12510392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments.
    Barry BW; Woodford R
    Br J Dermatol; 1975 Nov; 93(5):563-71. PubMed ID: 1203181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
    Korting HC; Maslen K; Gross G; Willers C
    J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of patients' satisfaction in using potent topical corticosteroid preparations.
    Shibata Y; Ikeda H; Kihira K
    Hiroshima J Med Sci; 2007 Dec; 56(3-4):33-9. PubMed ID: 18516932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality Testing of Tacrolimus Ointment Mixed with Various Type of Ointments or Creams.
    Nakane T; Doi H; Hirohara M; Hamashima H; Inoue Y
    Biol Pharm Bull; 2018; 41(11):1632-1637. PubMed ID: 30381662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity?
    Gao HY; Li Wan Po A
    Eur J Clin Pharmacol; 1994; 46(1):71-5. PubMed ID: 8005190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of hydrocortisone valerate 0.2% ointment.
    Sefton J; Loder JS; Kyriakopoulos AA
    Clin Ther; 1984; 6(3):282-93. PubMed ID: 6373007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
    Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
    Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of constituents in white soft paraffin on the efficacy of corticosteroid ointments in the vasoconstrictor test.
    Coldman MF; Lockerbie L
    J Pharm Pharmacol; 1971 Dec; 23():253S-254S. PubMed ID: 4401514
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of storage time on the release profile of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments.
    Suzuki T; Uchino T; Miyazaki Y; Kagawa Y
    Pharmazie; 2014 Feb; 69(2):104-8. PubMed ID: 24640598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
    Crijns MB; Nater JP; van Oostveen F; van der Valk PG
    Contact Dermatitis; 1984 Aug; 11(2):108-11. PubMed ID: 6488765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter.
    Queille-Roussel C; Poncet M; Schaefer H
    Br J Dermatol; 1991 Mar; 124(3):264-70. PubMed ID: 2018732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new type of topical corticoid. Principle and experimental activity control].
    Escande JP
    Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
    [No Abstract]   [Full Text] [Related]  

  • 19. Suitability of the upper back for corticosteroid vasoconstrictor assay.
    Duhra P; Ryatt KS
    Br J Dermatol; 1988 Sep; 119(3):406-7. PubMed ID: 3179212
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative skin blanching assay of corticosteroid creams using tristimulus colour analysis.
    Chan SY; Li Wan Po A
    J Pharm Pharmacol; 1992 May; 44(5):371-8. PubMed ID: 1359050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.